JP2016503066A5 - - Google Patents

Download PDF

Info

Publication number
JP2016503066A5
JP2016503066A5 JP2015549794A JP2015549794A JP2016503066A5 JP 2016503066 A5 JP2016503066 A5 JP 2016503066A5 JP 2015549794 A JP2015549794 A JP 2015549794A JP 2015549794 A JP2015549794 A JP 2015549794A JP 2016503066 A5 JP2016503066 A5 JP 2016503066A5
Authority
JP
Japan
Prior art keywords
weight percent
film composition
amount
oil
film
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2015549794A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016503066A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/077041 external-priority patent/WO2014100643A1/en
Publication of JP2016503066A publication Critical patent/JP2016503066A/ja
Publication of JP2016503066A5 publication Critical patent/JP2016503066A5/ja
Withdrawn legal-status Critical Current

Links

JP2015549794A 2012-12-21 2013-12-20 酢酸グラチラマーの経口経粘膜送達 Withdrawn JP2016503066A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261745243P 2012-12-21 2012-12-21
US61/745,243 2012-12-21
PCT/US2013/077041 WO2014100643A1 (en) 2012-12-21 2013-12-20 Oral transmucosal delivery of glatiramer acetate

Publications (2)

Publication Number Publication Date
JP2016503066A JP2016503066A (ja) 2016-02-01
JP2016503066A5 true JP2016503066A5 (cg-RX-API-DMAC7.html) 2017-02-02

Family

ID=50979258

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015549794A Withdrawn JP2016503066A (ja) 2012-12-21 2013-12-20 酢酸グラチラマーの経口経粘膜送達

Country Status (15)

Country Link
US (1) US20150328277A1 (cg-RX-API-DMAC7.html)
EP (1) EP2934493A4 (cg-RX-API-DMAC7.html)
JP (1) JP2016503066A (cg-RX-API-DMAC7.html)
KR (1) KR20150111919A (cg-RX-API-DMAC7.html)
CN (1) CN104869984A (cg-RX-API-DMAC7.html)
AU (1) AU2013361057A1 (cg-RX-API-DMAC7.html)
BR (1) BR112015014092A2 (cg-RX-API-DMAC7.html)
CA (1) CA2895457A1 (cg-RX-API-DMAC7.html)
EA (1) EA201591187A1 (cg-RX-API-DMAC7.html)
HK (2) HK1214522A1 (cg-RX-API-DMAC7.html)
IL (1) IL239279A0 (cg-RX-API-DMAC7.html)
MX (1) MX2015007794A (cg-RX-API-DMAC7.html)
SG (1) SG11201504461QA (cg-RX-API-DMAC7.html)
WO (1) WO2014100643A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201505050B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA025780B1 (ru) 2010-10-11 2017-01-30 Тева Фармасьютикал Индастриз Лтд. Цитокиновые биомаркеры в качестве биомаркеров, прогнозирующих клинический ответ на глатирамер ацетат
MX2014004309A (es) 2011-10-10 2015-07-06 Teva Pharma Polimorfismos de nucleotidos individuales utiles para predecir una respuesta clinica para el acetato de glatiramer.
UY35790A (es) 2013-10-21 2015-05-29 Teva Pharma Marcadores genéticos que predicen la respuesta al acetato de glatiramer
US10493122B2 (en) 2014-03-17 2019-12-03 Mapi Pharma Ltd. Sublingual delivery of glatiramer acetate
US10323289B2 (en) 2017-06-26 2019-06-18 Institut Pasteur Treatments to eliminate HIV reservoirs and reduce viral load

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0679002A (ja) * 1993-12-14 1994-03-22 Hisamitsu Pharmaceut Co Inc 経皮投与用パッチシステム
US6197331B1 (en) * 1997-07-24 2001-03-06 Perio Products Ltd. Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
US7022663B2 (en) * 2000-02-18 2006-04-04 Yeda Research And Development Co., Ltd. Oral, nasal and pulmonary dosage formulations of copolymer 1
US20020077278A1 (en) * 2000-06-05 2002-06-20 Yong V. Wee Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
US20030175328A1 (en) * 2002-03-06 2003-09-18 Adi Shefer Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin
NZ540318A (en) * 2002-10-31 2007-09-28 Umd Inc Therapeutic compositions for drug delivery to and through covering epithelia
EP2106790B1 (en) * 2004-03-12 2012-10-24 Biodel, Inc. Rapid acting drug delivery compositions
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
US20060205822A1 (en) * 2004-12-22 2006-09-14 Forest Laboratories, Inc. 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
US20060210616A1 (en) * 2005-03-17 2006-09-21 Linder Barry J Therapeutic patch for ophthalmologic and cosmetic use
US20070021325A1 (en) * 2005-07-21 2007-01-25 Mediplex Corporation Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
KR100809404B1 (ko) * 2005-12-28 2008-03-05 (주)스피어테크 리포좀화 시킨 나노용매를 함유하는 경피흡수 점착시트형 화장료 조성물 및 제조방법
WO2007087188A2 (en) * 2006-01-20 2007-08-02 Merck & Co., Inc. Taste-masked tablets and granules
RU2436565C2 (ru) * 2006-02-17 2011-12-20 Новартис Аг Распадающиеся пероральные пленки
WO2008006226A1 (en) * 2006-07-14 2008-01-17 Wine, Harvey Transdermal formulations of synthetic cannabinoids and nano colloidal silica
AU2007329375A1 (en) * 2006-12-04 2008-06-12 The Board Of Trustees Of The University Of Illinois Compositions and methods to treat cancer with cupredoxins and CpG rich DNA
JP5177447B2 (ja) * 2007-06-07 2013-04-03 佐藤製薬株式会社 速溶性及び可撓性を有するフィルム製剤
WO2009005814A2 (en) * 2007-07-03 2009-01-08 Marchitto Kevin S Drug-delivery patch comprising a dissolvable layer and uses thereof
US20100278899A1 (en) * 2007-12-06 2010-11-04 Lintec Corporation Edible film

Similar Documents

Publication Publication Date Title
JP2012502037A5 (cg-RX-API-DMAC7.html)
JP2016525572A5 (cg-RX-API-DMAC7.html)
ES2545395T3 (es) Asociación de ivermectina con brimonidina para el tratamiento o prevención de la rosácea
AU2011221889B2 (en) Film preparation containing medicament with unpleasant taste
NZ626672A (en) Solid nicotine-comprising dosage form with reduced organoleptic disturbance
JP6301460B2 (ja) レボセチリジンおよびモンテルカストを含む、改善された安定性を有する複合顆粒製剤
JP2014533504A5 (cg-RX-API-DMAC7.html)
BRPI0710485A2 (pt) composições e métodos úteis para tratamento de doenças respiratórias
CN104490833B (zh) 一种依折麦布口腔崩解片及其制备方法
RU2017101833A (ru) Орально распадающийся пленочный препарат, содержащий тадалафил, и способ его приготовления
BRPI0710483A2 (pt) composições e kits úteis para o tratamento de doenças respiratórias
JP2008511569A5 (cg-RX-API-DMAC7.html)
JP2005526104A5 (cg-RX-API-DMAC7.html)
HRP20171511T1 (hr) Ivabradin-hidroklorid, oblik iv
RU2015102575A (ru) Жидкие композиции рацекадотрила
JP2024510035A (ja) エピネフリン粒子を含む複合口腔粘膜フィルム組成物
JP2014500246A5 (cg-RX-API-DMAC7.html)
WO2009136979A2 (en) Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof
CN106659751A (zh) 口腔可分散膜
JP2012515723A5 (cg-RX-API-DMAC7.html)
CN104840467A (zh) 五环三萜类肠道病毒ev71抑制剂、其药物组合物及医药用途
RU2010122062A (ru) Улучшенное покрытие для таблеток
CN103432105A (zh) 一种美克洛嗪口腔用膜剂及其制备方法
JP2005524670A5 (cg-RX-API-DMAC7.html)
RU2016130051A (ru) Жидкие композиции рацекадотрила